Generic Injectable Market to Expand with Significant CAGR During 2019-2029 (1) - PowerPoint PPT Presentation

About This Presentation

Generic Injectable Market to Expand with Significant CAGR During 2019-2029 (1)


Generic Injectable Market – PowerPoint PPT presentation

Number of Views:1
Slides: 10
Provided by: is9792
Category: Other


Transcript and Presenter's Notes

Title: Generic Injectable Market to Expand with Significant CAGR During 2019-2029 (1)

Generic Injectable Market to Expand with
Significant CAGR During 2019-2029
  • March 2020

Report Id REP-GB-6051 Published On
Feb-2020 Category Healthcare, Pharmaceuticals
Medical Devices
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage
  • Customized Research
  • Syndicated Research
  • Investment Research
  • Social Media Research

  • Automotive and Transportation
  • Electronics, Semiconductor, and ICT
  • Retail and Consumer Products
  • Industrial Automation and Equipment
  • Chemicals Materials
  • Food and Beverages
  • Services and Utilities
  • Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email
Research Methodology (1/2)
  • Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)
  • Identifying key opinion leaders
  • Questionnaire design
  • In-depth interviews
  • Coverage across value chain
  • Key industry experts
  • Channel study
  • Developments
  • Market dynamics
  • Products
  • Conclusions

  • Market participants
  • Key strengths
  • Product portfolio
  • Mapping as per value chain
  • Key focus segments

Primary Research
Secondary Research
Paid Publications
  • Linkedin
  • Zoominfo
  • Salesforce
  • Avention
  • Factiva
  • GBI
  • Genios
  • Meltwater
  • Company websites
  • Company annual reports
  • White papers
  • Financial reports

includes sources of databases
Generic Injectable Market Analysis
  • Generic Injectable Market to Expand with
    Significant CAGR During 2019-2029
  • Currently at a nascent stage, the global generic
    injectable market is projected to witness
    exponential growth in sales at around 12 CAGR
    during 2019 - 2029. Over the course of forecast
    period, generic injectable sales will experience
    3X growth, as indicated by a new Future Market
    Insights (FMI) study. Increasing patient
    preference for self-administration of drugs is
    primarily developing a fertile ground for the
    generic injectable market, says the report.
  • "The generic pharmaceuticals sector is gaining a
    boost from frequent FDA approvals. Launch of
    low-cost injectables through investments in
    consolidations and mergers has been a major
    highlight," states the FMI report.
  • Key Takeaways Generic Injectable Market
  • Demand for monoclonal antibodies (mAbs) would
    remain significant vaccines are gaining
  • Generic injectable market continues to see
    emergence of high-value opportunities in North
    America and Europe.
  • Asian markets would capture investors' attention,
    owing to solid growth in pharma production
    capacities and technology penetration.
  • High preference for small molecule drugs will

Generic Injectable Market Analysis
  • Generic injectables continue to witness
    significant adoption in pain management.
  • Large molecule injectables are set to outperform
    their small counterparts by 2022.
  • Key Market Growth Drivers
  • Expansion of orphan drug and parenteral products
    spaces remains a strong factor driving generic
    injectable sales.
  • Increasing preference for cost-efficient
    biologics such as mAbs and vaccines over drugs is
    in favor of market growth.
  • Reduced development time and increasing
    manufacturers' investments in consolidation are
    bolstering demand for generic injectables.
  • Key Restraints
  • Hefty operational costs will remain the key
    constraint facing generic injectable
  • Tightening competition from low-cost
    manufacturers continues to challenge large-scale
    players in generic injectable market.

Generic Injectable Market Analysis
  • Competition Analysis Generic Injectable Market
  • This FMI study has covered some of the most
    prominent companies active in the generic
    injectable market, which include, but are not
    limited to, Pfizer Inc., Hospira Inc., Hikma, and
    Mylan. Key market players continue to maintain
    their strategic focus on expansion of business
    through mergers. Entering strategic distribution
    agreements will be a preferred move of market
    leaders in an effort to capture the untapped
    growth potential of generic injectable market.
  • Development of new development pipelines and
    extension of product portfolios continue to be
    the key strategies of players that look forward
    to unlock opportunities in the US generic
    injectable market. Increasing competition to
    penetrate developed regional markets is
    attracting investments towards introduction of
    patented complex biologics. Association with CMOs
    and CDMOs will be a profitable developmental
    strategy in terms of productivity and operational
    costs, says the report.
  • More about the Report
  • This Future Market Insights study of 239 pages
    offers actionable insights on the generic
    injectable market. The market analysis is based
    on product (monoclonal antibodies,
    immunoglobulin, cytokines, insulin, peptide
    hormones, blood factors, peptide antibiotics,
    vaccines, small molecule antibiotics,
    chemotherapy agents, and others), molecule type
    (small molecule and large molecule), application
    (oncology, infectious diseases, diabetes, blood
    disorders, hormonal disorders, musculoskeletal
    disorders, CNS diseases, pain management, and
    cardiovascular diseases), route of administration
    (IV, IM, and SC), and distribution channels
    (hospital pharmacies, retail pharmacies, drug
    stores, and online pharmacies) across seven
    regions (Latin America, North America, Europe,
    South Asia, East Asia, Oceania, and MEA).

Generic Injectable Market Analysis
  • Sourcehttps//
  • Explore FMI's Detailed Coverage of Related
  • Corneal Ulcer Treatment Market
  • Juvenile Idiopathic Arthritis Diagnostics Market
  • About Future Market Insights (FMI)
  • Future Market Insights (FMI) is a leading
    provider of market intelligence and consulting
    services, serving clients in over 150 countries.
    FMI is headquartered in London, the global
    financial capital, and has delivery centers in
    the U.S. and India. FMI's latest market research
    reports and industry analysis help businesses
    navigate challenges and take critical decisions
    with confidence and clarity amidst breakneck

Generic Injectable Market Analysis
  • Abhishek BudholiyaUnit No AU-01-H Gold Tower
    (AU), Plot No JLT-PH1-I3A,Jumeirah Lakes
    Towers, Dubai,United Arab EmiratesMARKET ACCESS
    DMCC InitiativeFor Sales Enquiries
    sales_at_futuremarketinsights.comFor Media
    Enquiries press_at_futuremarketinsights.comFuture
    Market Insights

To know more about us, please visit our website For sales queries
or new topics email us on sales_at_futuremarketinsi For media queries, contact the press
office at For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)
Write a Comment
User Comments (0)